Monoclonal Antibodies Market Report – Research, Industry Analysis Reports and Market Demands

Global (United States, European Union and China) Monoclonal Antibodies Market Research Report 2019-2025

Request for Sample of this report

Buy now

Table of Content

1 Report Overview

1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
- 1.3.1 Global Monoclonal Antibodies Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Cancer
- 1.3.3 Autoimmune Diseases
- 1.3.4 Infection
- 1.3.5 Hematological Diseases
- 1.3.6 Others
1.4 Market Segment by Application
- 1.4.1 Global Monoclonal Antibodies Market Share by Application (2019-2025)
- 1.4.2 Oncology
- 1.4.3 Autoimmune and inflammatory diseases
- 1.4.4 Respiratory diseases
- 1.4.5 Ophthalmology
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends

2.1 Global Monoclonal Antibodies Market Size
- 2.1.1 Global Monoclonal Antibodies Revenue 2014-2025
- 2.1.2 Global Monoclonal Antibodies Sales 2014-2025
2.2 Monoclonal Antibodies Growth Rate by Regions
- 2.2.1 Global Monoclonal Antibodies Sales by Regions 2014-2019
- 2.2.2 Global Monoclonal Antibodies Revenue by Regions 2014-2019
2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers

3 Market Share by Manufacturers

3.1 Monoclonal Antibodies Sales by Manufacturers
- 3.1.1 Monoclonal Antibodies Sales by Manufacturers 2014-2019
- 3.1.2 Monoclonal Antibodies Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
- 3.2.1 Monoclonal Antibodies Revenue by Manufacturers (2014-2019)
- 3.2.2 Monoclonal Antibodies Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.3 Monoclonal Antibodies Price by Manufacturers
3.4 Key Manufacturers Monoclonal Antibodies Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Monoclonal Antibodies Market
3.6 Key Manufacturers Monoclonal Antibodies Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Sales and Revenue for Each Type
- 4.1.1 Cancer Sales and Revenue (2014-2019)
- 4.1.2 Autoimmune Diseases Sales and Revenue (2014-2019)
- 4.1.3 Infection Sales and Revenue (2014-2019)
- 4.1.4 Hematological Diseases Sales and Revenue (2014-2019)
- 4.1.5 Others Sales and Revenue (2014-2019)
4.2 Global Monoclonal Antibodies Sales Market Share by Type
4.3 Global Monoclonal Antibodies Revenue Market Share by Type
4.4 Monoclonal Antibodies Price by Type

5 Market Size by Application

5.1 Overview
5.2 Global Monoclonal Antibodies Sales by Application

6 United States

6.1 United States Monoclonal Antibodies Breakdown Data by Company
6.2 United States Monoclonal Antibodies Breakdown Data by Type
6.3 United States Monoclonal Antibodies Breakdown Data by Application

7 European Union

7.1 European Union Monoclonal Antibodies Breakdown Data by Company
7.2 European Union Monoclonal Antibodies Breakdown Data by Type
7.3 European Union Monoclonal Antibodies Breakdown Data by Application

8 China

8.1 China Monoclonal Antibodies Breakdown Data by Company
8.2 China Monoclonal Antibodies Breakdown Data by Type
8.3 China Monoclonal Antibodies Breakdown Data by Application

9 Rest of World

9.1 Rest of World Monoclonal Antibodies Breakdown Data by Company
9.2 Rest of World Monoclonal Antibodies Breakdown Data by Type
9.3 Rest of World Monoclonal Antibodies Breakdown Data by Application
9.4 Rest of World Monoclonal Antibodies Breakdown Data by Countries
- 9.4.1 Rest of World Monoclonal Antibodies Sales by Countries
- 9.4.2 Rest of World Monoclonal Antibodies Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia

10 Company Profiles

11 Value Chain and Sales Channels Analysis

11.1 Value Chain Analysis
11.2 Sales Channels Analysis
- 11.2.1 Monoclonal Antibodies Sales Channels
- 11.2.2 Monoclonal Antibodies Distributors
11.3 Monoclonal Antibodies Customers

12 Market Forecast

12.1 Global Monoclonal Antibodies Sales and Revenue Forecast 2019-2025
12.2 Global Monoclonal Antibodies Sales Forecast by Type
12.3 Global Monoclonal Antibodies Sales Forecast by Application
12.4 Monoclonal Antibodies Forecast by Regions
- 12.4.1 Global Monoclonal Antibodies Sales Forecast by Regions 2019-2025
- 12.4.2 Global Monoclonal Antibodies Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
  - 14.1.1.1 Research Programs/Design
  - 14.1.1.2 Market Size Estimation
  - 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
  - 14.1.2.1 Secondary Sources
  - 14.1.2.2 Primary Sources
14.2 Author Details

Description

Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
In 2019, the market size of Monoclonal Antibodies is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Monoclonal Antibodies.

This report studies the global market size of Monoclonal Antibodies, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Monoclonal Antibodies sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
AbbVie
Roche
Johnson & Johnson
Amgen
Merck
BMS
Eli Lilly
Formation Biologics
Genmab
GlaxoSmithKline
Human Genome Sciences
mmunogen
MedImmune
Novartis
Pfizer
Seattle Genetics
Stemcentrx
Synthon Biopharmaceuticals
Takeda
Teva

Market Segment by Product Type
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Others

Market Segment by Application
Oncology
Autoimmune and inflammatory diseases
Respiratory diseases
Ophthalmology

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Monoclonal Antibodies status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Monoclonal Antibodies manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Monoclonal Antibodies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025